Therapie und Prognose des iNPH

U. Meier; J. Lemcke

doi:10.1055/s-0038-1628291

Nervenheilkunde, Table of Contents

Nervenheilkunde 2012; 31(09): 640-644
DOI: 10.1055/s-0038-1628291

Serie iNPH

Schattauer GmbH

Therapie und Prognose des iNPH

Therapy and prognosis for idiopathic normal pressure hydrocephalus

Authors

U. Meier

¹Klinik für Neurochirurgie, Unfallkrankenhaus Berlin
J. Lemcke

¹Klinik für Neurochirurgie, Unfallkrankenhaus Berlin

Abstract

Zusammenfassung

Ventikuloperitoneale Shunts stellen die Standardtherapie des idiopathischen Normaldruckhydrozephalus dar. Die Entwicklung der Ventiltechnologien ging von einfachen Differenzdruckventilen aus und führte über programmierbare Ventile hin zu modernen programmierbaren Ventilen mit Gravitationseinheit. Im Rahmen dieser Entwicklung konnten die Effektivität der Therapie gesteigert und die Komplikationsrate gesenkt werden. Prognostisch hat sich die Zahl der Shuntresponder von ca. 60% in den 1960er-Jahren bis heute auf bis zu 90% gesteigert.

Summary

Venticuloperitoneal shunts represent the standard therapy for patients with idiopathic normal pressure hydrocephalus. The development of valve technologies started from simple differential pressure valves and led over programmable valves to programmable valves with gravitational unit. During this development the effectiveness of the valves could be improved while the rate of complication was lowered. The proportion of shunt responders raised from 60% in the 1960s to 90% today.

Schlüsselwörter

Idiopathischer Normaldruckhydrozephalus - ventrikuloperitonealer Shunt - Gravitationsventil - SVASONA-Studie - Prognose

Keywords

Idiopathic normal pressure hydrocephalus - ventriculoperitoneal shunt - gravitational valve - SVASONA study - prognosis

Full Text

References

Literatur
1 Esmonde T, Cooke S. Shunting for normal pressure hydrocephalus (NPH). Cochrane Database Syst Rev 2002; (3): CD003157.
2 Dandy WE. Extirpation of the choroid plexus of the lateral ventricles in communicating hydrocephalus. Ann Surg 1918; 68 (Suppl. 06) 569-79.
3 Aschoff A, Kremer P, Hashemi B, Kunze S. The scientific history of hydrocephalus and its treatment. Neurosurg Rev 1999; 22 2–3 67-93.
4 Aschoff A, Kremer P, Benesch C, Fruh K, Klank A, Kunze S. Overdrainage and shunt technology. A critical comparison of programmable, hydrostatic and variable-resistance valves and flow-reducing devices. Childs Nerv Syst 1995; 11 (Suppl. 04) 193-202.
5 Aschoff A, Kramer P, Benesch C, Klank A. Shunt-technology and overdrainage – a critical review of hydrostatic, programmable and variable-resistance-valves and flow-reducing devices. Eur J Pediatr Surg 1991; 1 Suppl 1: 49-50.
6 Czosnyka Z, Czosnyka M, Richards HK, Pickard JD. Laboratory testing of hydrocephalus shunts – conclusion of the U.K. Shunt evaluation programme. Acta Neurochir (Wien) 2002; 144 (Suppl. 06) 525-38.
7 Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, Hermans J. The Dutch normal-pressure hydrocephalus study. How to select patients for shunting?. An analysis of four diagnostic criteria. Surg Neurol 2000; 53 (Suppl. 03) 201-7.
8 Boon AJ, Tans JT, Delwel EJ, Egeler-Peerdeman SM, Hanlo PW, Wurzer HA, Avezaat CJ, de Jong DA, Gooskens RH, Hermans J. Dutch Normal-Pressure Hydrocephalus Study: randomized comparison of low- and medium-pressure shunts. J Neurosurg 1998; 88 (Suppl. 03) 490-5.
9 de Jong DA, Delwel EJ, Avezaat CJ. Hydrostatic and hydrodynamic considerations in shunted normal pressure hydrocephalus. Acta Neurochir (Wien) 2000; 142 (Suppl. 03) 241-7.
10 Frim DM, Goumnerova LC. In vivo intracranial pressure dynamics in patients with hydrocephalus treated by shunt placement. J Neurosurg 2000; 92 (Suppl. 06) 927-32.
11 Kiefer M, Eymann R, Meier U. Five years experience with gravitational shunts in chronic hydrocephalus of adults. Acta Neurochir (Wien) 2002; 144 (Suppl. 08) 755-67.
12 Meier U, Kiefer M, Sprung C. Evaluation of the Miethke dual-switch valve in patients with normal pressure hydrocephalus. Surg Neurol 2004; 61 (Suppl. 02) 119-27.
13 Sprung C, Schlosser HG, Lemcke J, Meier U, Messing-Junger M, Trost HA, Weber F, Schul C, Rohde V, Ludwig HC, Hopfner J, Sepehrnia A, Mirzayan MJ, Krauss JK. The adjustable proGAV shunt: a prospective safety and reliability multicenter study. Neurosurgery 2010; 66 (Suppl. 03) 465-74.
14 Zeilinger FS, Reyer T, Meier U, Kintzel D. Clinical experiences with the dual-switch valve in patients with normal pressure hydrocephalus. Acta Neurochir Suppl 2000; 76: 559-62.
15 Meier U, Kiefer M, Neumann U, Lemcke J. On the optimal opening pressure of hydrostatic valves in cases of idiopathic normal-pressure hydrocephalus: a prospective randomized study with 123 patients. Acta Neurochir Suppl 2006; 96: 358-63.
16 Meier U. Outcome of idiopathic normal pressure hydrocephalus after surgery with gravity valves. Neurosurg Q 2004; 14: 119-26.
17 Lemcke J, Meier U. Improved outcome in shunted iNPH with a combination of a Codman Hakim Programmable Valve and an Aesculap-Miethke ShuntAssistant. Central European Neurosurgery 2010; 71 (Suppl. 03) 113-6.
18 Meier U, Lemcke J. First clinical experiences in patients with idiopathic normal-pressure hydrocephalus with the adjustable gravity valve manufactured by Aesculap (proGAV). Acta Neurochir Suppl 2006; 96: 368-72.
19 Lemcke J, Meier U, Muller C, Fritsch M, Eymann R, Kiefer M, Kehler U, Langer N, Rohde V, Ludwig HC, Weber F, Remenez V, Schuhmann M, Stengel D. Is it possible to minimize overdrainage complications with gravitational units in patients with idiopathic normal pressure hydrocephalus? Protocol of the randomized controlled SVASONA Trial (ISRCTN51046698). Acta Neurochir Suppl 2010; 106: 113-5.
20 Meier U, Lemcke J. Diagnostic methods of norm-alpressure hydrocephalus. Schweiz Arch Neurol Psychiatr 2007; 158: 139-49.
21 Meier U, Lemcke J, Neumann U. Predictors of outcome in patients with normal-pressure hydrocephalus. Acta Neurochir Suppl 2006; 96: 352-7.
22 Sorteberg A, Eide PK, Fremming AD. A prospective study on the clinical effect of surgical treatment of normal pressure hydrocephalus: the value of hydrodynamic evaluation. Br J Neurosurg 2004; 18 (Suppl. 02) 149-57.
23 Poca MA, Mataro M, del Mar MM, Arikan F, Junque C, Sahuquillo J. Is the placement of shunts in patients with idiopathic normal-pressure hydrocephalus worth the risk? Results of a study based on continuous monitoring of intracranial pressure. J Neurosurg 2004; 100 (Suppl. 05) 855-66.
24 Murakami M, Hirata Y, Kuratsu JI. Predictive assessment of shunt effectiveness in patients with idiopathic normal pressure hydrocephalus by determining regional cerebral blood flow on 3D stereotactic surface projections. Acta Neurochir (Wien) 2007; 149 (10) 991-7.
25 Gallia GL, Rigamonti D, Williams MA. The diagnosis and treatment of idiopathic normal pressure hydrocephalus. Nat Clin Pract Neurol 2006; 2 (Suppl. 07) 375-81.
26 Chang S, Agarwal S, Williams MA, Rigamonti D, Hillis AE. Demographic factors influence cognitive recovery after shunt for normal-pressure hydrocephalus. Neurologist 2006; 12 (Suppl. 01) 39-42.
27 Duinkerke A, Williams MA, Rigamonti D, Hillis AE. Cognitive recovery in idiopathic normal pressure hydrocephalus after shunt. Cogn Behav Neurol 2004; 17 (Suppl. 03) 179-84.
28 Graff-Radford NR, Godersky JC. Normal-pressure hydrocephalus. Onset of gait abnormality before dementia predicts good surgical outcome. Arch Neurol 1986; 43 (Suppl. 09) 940-2.
29 Kiefer M, Eymann R, Steudel WI. Outcome predictors for normal-pressure hydrocephalus. Acta Neurochir Suppl 2006; 96: 364-7.
30 Sand T, Bovim G, Grimse R, Myhr G, Helde G, Cappelen J. Idiopathic normal pressure hydrocephalus: the CSF tap-test may predict the clinical response to shunting. Acta Neurol Scand 1994; 89 (Suppl. 05) 311-6.
31 Savolainen S, Hurskainen H, Paljarvi L, Alafuzoff I, Vapalahti M. Five-year outcome of normal pressure hydrocephalus with or without a shunt: predictive value of the clinical signs, neuropsychological evaluation and infusion test. Acta Neurochir (Wien) 2002; 144 (Suppl. 06) 515-23.
32 Vassilouthis J. Poor prognosis/good outcome in patients with NPH. J Neurosurg 2006; 104 (Suppl. 06) 986-8.
33 Delwel EJ, de Jong DA, Avezaat CJ. The prognostic value of clinical characteristics and parameters of cerebrospinal fluid hydrodynamics in shunting for idiopathic normal pressure hydrocephalus. Acta Neurochir (Wien) 2005; 147 (10) 1037-42.
34 Meier U, Lemcke J. Clinical outcome of patients with idiopathic normal pressure hydrocephalus three years after shunt implantation. Acta Neurochir Suppl 2006; 96: 377-80.
35 Black PM. Idiopathic normal-pressure hydrocephalus. Results of shunting in 62 patients. J Neurosurg 1980; 52 (Suppl. 03) 371-7.
36 Dixon GR, Friedman JA, Luetmer PH, Quast LM, McClelland RL, Petersen RC, Maher CO, Ebersold MJ. Use of cerebrospinal fluid flow rates measured by phase-contrast MR to predict outcome of ventriculoperitoneal shunting for idiopathic normal-pressure hydrocephalus. Mayo Clin Proc 2002; 77 (Suppl. 06) 509-14.
37 Kahlon B, Sundbarg G, Rehncrona S. Comparison between the lumbar infusion and CSF tap tests to predict outcome after shunt surgery in suspected normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002; 73 (Suppl. 06) 721-6.
38 Krauss JK, Regel JP. The predictive value of ventricular CSF removal in normal pressure hydrocephalus. Neurol Res 1997; 19 (Suppl. 04) 357-60.
39 Marmarou A, Black P, Bergsneider M, Klinge P, Relkin N. Guidelines for management of idiopathic normal pressure hydrocephalus: progress to date. Acta Neurochir Suppl 2005; 95: 237-40.
40 McConnell KA, Zou KH, Chabrerie AV, Bailey NO, Black PM. Decreases in ventricular volume correlate with decreases in ventricular pressure in idiopathic normal pressure hydrocephalus patients who experienced clinical improvement after implantation with adjustable valve shunts. Neurosurgery 2004; 55 (Suppl. 03) 582-92.
41 Meier U, Lemcke J, Al-Zain F. Course of disease in patients with idiopathic normal pressure hydrocephalus (iNPH): a follow-up study 3, 4 and 5 years following shunt implantation. Acta Neurochir Suppl 2008; 102: 125-7.
42 Mori K. Management of idiopathic normal-pressure hydrocephalus: a multiinstitutional study conducted in Japan. J Neurosurg 2001; 95 (Suppl. 06) 970-3.
43 Walchenbach R, Geiger E, Thomeer RT, Vanneste JA. The value of temporary external lumbar CSF drainage in predicting the outcome of shunting on normal pressure hydrocephalus. J Neurol Neurosurg Psychiatry 2002; 72 (Suppl. 04) 503-6.
44 Zemack G, Romner B. Adjustable valves in normal-pressure hydrocephalus: a retrospective study of 218 patients. Neurosurgery 2002; 51 (Suppl. 06) 1392-400.
45 Ishikawa M, Hashimoto M, Kuwana N, Mori E, Miyake H, Wachi A, Takeuchi T, Kazui H, Koyama H. Guidelines for management of idiopathic normal pressure hydrocephalus. Neurol Med Chir (Tokyo) 2008; 48 Suppl: S1-23.